One-year results from a Phase 3 clinical trial show early intervention with Eylea (aflibercept), lessened diabetic retinopathy severity and prevented serious vision-threatening complications,
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for a novel gene therapy for the treatment of a rare inherited retinal degenerative disease (IRD) caused by a
Patients suffering vision loss in both eyes due to limbal stem cell deficiency (LSCD) might benefit from a stem cell transplant using donated cells, according to a new randomised, controlled study in
Eye-tracking platform EyeSync could become the standard of care for concussion following the FDA’s granting of a “breakthrough device” designation for SincThink’s virtual reality technology. The move
Retina International (RI) has launched a global toolkit on inherited retinal diseases (IRDs), a central hub with information aimed at IRD patients, their families and carers, health care
Bausch & Lomb (B+L) has launched an initiative, What Women Want, designed to help promote contact lenses and increase retention among female wearers.Explaining the campaign, professional affairs
A new simulator allows patients to experience how their vision will improve before undergoing surgery.Developed by scientists from the Spanish National Research Council (CSIC), the device enables
Scientists have developed a biological system which enables cells to form a desired shape by moulding their surrounding material to create, in the first instance, the world's first self-curving
Vuzix Blade has received a CES 2019 innovation award for the design and engineering of its augmented-reality (AR) smart glasses. The company says its glasses provide a natural view of the real
Inserting encapsulated cells that excrete ciliary neurotrophic factor (Renexus, Neurotech) into the back of the eye could be a promising treatment for glaucoma, reports Ophthalmology Times.Stanford
A number of big players have announced they will work together to create a blockchain-based ecosystem for the healthcare industry. Aetna, Anthem, Health Care Service Corporation, PNC Bank and IBM say
The first patient in a German clinical study has been implanted with an Eyemate-SC eye pressure sensor for continual glaucoma monitoring.Ophthalmic medical device company Implandata said the patient
